Applying machine learning to predict real-world individual treatment effects: insights from a virtual patient cohort
G Fang, IE Annis, J Elston-Lafata… - Journal of the American …, 2019 - academic.oup.com
Objective We aimed to investigate bias in applying machine learning to predict real-world
individual treatment effects. Materials and Methods Using a virtual patient cohort, we …
individual treatment effects. Materials and Methods Using a virtual patient cohort, we …
Renin‐angiotensin‐aldosterone system inhibitors and major cardiovascular events and acute kidney injury in patients with coronary artery disease
Background Renin‐angiotensin‐aldosterone system inhibitors (RAASIs) are recommended
for most patients with coronary artery disease (CAD). However, there is debate across …
for most patients with coronary artery disease (CAD). However, there is debate across …
Disparities by sex in P2Y12 inhibitor therapy duration, or differences in the balance of ischaemic-benefit and bleeding-risk clinical outcomes in older women versus …
RP Hickson, AM Kucharska-Newton, JE Rodgers… - BMJ open, 2021 - bmjopen.bmj.com
Objectives To determine if comparable older women and men received different durations of
P2Y12 inhibitor therapy following acute myocardial infarction (AMI) and if therapy duration …
P2Y12 inhibitor therapy following acute myocardial infarction (AMI) and if therapy duration …
A comparative study assessing the incidence and degree of hyperkalemia in patients on angiotensin-converting enzyme inhibitors versus angiotensin-receptor …
JR Salik, SB Golas, TH McCoy - Journal of Human Hypertension, 2022 - nature.com
Overview Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin-receptor
blockers (ARB) are the most commonly prescribed anti-hypertensive medications in the …
blockers (ARB) are the most commonly prescribed anti-hypertensive medications in the …
Effects of angiotensin II receptor blockers on serum potassium level and hyperkalemia risk: retrospective single-centre analysis
S Fukushima, M Oishi, H Aso, K Arai… - European Journal of …, 2023 - ejhp.bmj.com
Objective To examine the effect of angiotensin II receptor blocker (ARB) treatment on serum
potassium level and hyperkalaemia risk in a clinical setting with inpatients and outpatients …
potassium level and hyperkalaemia risk in a clinical setting with inpatients and outpatients …
Low body mass index is a risk factor for hyperkalaemia associated with angiotensin converting enzyme inhibitors and angiotensin II receptor blockers treatments
T Hirai, R Yamaga, A Fujita… - Journal of Clinical …, 2018 - Wiley Online Library
What is known and objective Angiotensin converting enzyme inhibitors (ACEI) and
angiotensin II receptor blockers (ARB) represent the cornerstones of hypertension and …
angiotensin II receptor blockers (ARB) represent the cornerstones of hypertension and …
Use of renin angiotensin system blockers after acute kidney injury: balancing tradeoffs
RJ Alpern, AJ Peixoto - JAMA Internal Medicine, 2018 - jamanetwork.com
Acute kidney injury (AKI) is a common complication among acutely ill hospitalized patients.
Depending on the definition used, AKI complicates 1% to 25% of intensive care unit …
Depending on the definition used, AKI complicates 1% to 25% of intensive care unit …
Association between serum 25‐hydroxyvitamin D and the effects of Angiotensin II receptor blocker on renal function among African Americans: A post hoc analysis of …
L Chen, H Zhu, GA Harshfield… - The Journal of Clinical …, 2020 - Wiley Online Library
We tested the hypothesis that vitamin D status may modify the effect of Angiotensin II
receptor blocker (ARB) on renal function among African Americans. Sixty‐four participants …
receptor blocker (ARB) on renal function among African Americans. Sixty‐four participants …
[PDF][PDF] INSTITUTION AND LOCATION DEGREE YEAR (s) FIELD OF STUDY
JG Robinson - public-health.uiowa.edu
9. Donovan BM, Breheny PJ, Robinson JG, Baer RJ, Saftlas AF, Bao W, Greiner AL, Carter
KD, Oltman SP, Rand L, Jelliffe-Pawlowski LL, Ryckman KK (2019). Development and …
KD, Oltman SP, Rand L, Jelliffe-Pawlowski LL, Ryckman KK (2019). Development and …
[PDF][PDF] 病院の医療情報データを活用した薬物治療の有効性や安全性の評価に関する研究
福島栄 - nihon-u.repo.nii.ac.jp
病院における薬剤師の業務は, これまでは調剤や医薬品管理等の薬剤部内での処方に対する疑義
照会や薬剤の情報提供といった単一的な業務が主であった. しかし, 2010 年 4 …
照会や薬剤の情報提供といった単一的な業務が主であった. しかし, 2010 年 4 …